middle.news
How 4DMedical’s CT:VQ™ Is Revolutionising Lung Imaging and Driving 43% SaaS Growth
8:56am on Friday 27th of February, 2026 AEDT
•
Healthcare
Read Story
How 4DMedical’s CT:VQ™ Is Revolutionising Lung Imaging and Driving 43% SaaS Growth
8:56am on Friday 27th of February, 2026 AEDT
Key Points
FDA clearance and CMS reimbursement secured for CT:VQ™
43% growth in global SaaS delivery sites to 430 locations
$150 million institutional placement completed in January 2026
Rapid adoption by leading US academic medical centres
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
4DMEDICAL (ASX:4DX)
OPEN ARTICLE